Page 2059 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2059

1828   Part XI  Transfusion Medicine


           editors:  Handbook  of  Pediatric  Transfusion  Medicine,  London,  2004,   29.  Eder AF: Review: acute Donath-Landsteiner hemolytic anemia. Immu-
           Elsevier Academic Press, pp 181–189.                  nohematology 21(2):56–62, 2005.
        17.  Meliones JN, Hansell DR: Extracorporeal membrane oxygenation: The   30.  Bolan CD, Yau YY, Cullis HC, et al: Pediatric large-volume leukapher-
           role of blood components. In Chambers LA, Isssitt LA, editors: Support-  esis:  a  single  institution  experience  with  heparin  versus  citrate-based
           ing the pediatric transfusion recipient, Bethesda, MD, 1994, AABB, pp   anticoagulant regimens. Transfusion 44(2):229–238, 2004.
           87–107.                                            31.  Gilbert  GL,  Hayes  K,  Hudson  IL,  et al:  Prevention  of  transfusion-
        18.  Hendrickson JE, Shaz BH, Pereira G, et al: Coagulopathy is prevalent   acquired  cytomegalovirus  infection  in  infants  by  blood  filtration  to
           and  associated  with  adverse  outcomes  in  transfused  pediatric  trauma   remove leucocytes. Neonatal Cytomegalovirus Infection Study Group.
           patients. J Pediatr 160(2):204–209 e3, 2012.          Lancet 1(8649):1228–1231, 1989.
        19.  Holcomb  JB,  Tilley  BC,  Baraniuk  S,  et al:  Transfusion  of  plasma,   32.  Leukocyte reduction and ultraviolet B irradiation of platelets to prevent
           platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality   alloimmunization and refractoriness to platelet transfusions. The Trial
           in patients with severe trauma: the PROPPR randomized clinical trial.   to Reduce Alloimmunization to Platelets Study Group. N Engl J Med
           JAMA 313(5):471–482, 2015.                            337(26):1861–1869, 1997.
        20.  Dehmer JJ, Adamson WT: Massive transfusion and blood product use in   33.  Fergusson  D,  Hebert  PC,  Lee  SK,  et al:  Clinical  outcomes  following
           the pediatric trauma patient. Semin Pediatr Surg 19(4):286–291, 2010.  institution of universal leukoreduction of blood transfusions for prema-
        21.  Adams RJ, Brambilla D: Discontinuing prophylactic transfusions used to   ture infants. JAMA 289(15):1950–1956, 2003.
           prevent stroke in sickle cell disease. N Engl J Med 353(26):2769–2778,   34.  Josephson CD, Caliendo AM, Easley KA, et al: Blood transfusion and
           2005.                                                 breast  milk  transmission  of  cytomegalovirus  in  very  low-birth-weight
        22.  Adams  RJ,  McKie  VC,  Hsu  L,  et al:  Prevention  of  a  first  stroke  by   infants: a prospective cohort study. JAMA Pediatr 168(11):1054–1062,
           transfusions in children with sickle cell anemia and abnormal results on   2014.
           transcranial Doppler ultrasonography. N Engl J Med 339(1):5–11, 1998.  35.  Yeager AS, Grumet FC, Hafleigh EB, et al: Prevention of transfusion-
        23.  Vichinsky EP, Luban NL, Wright E, et al: Prospective RBC phenotype   acquired  cytomegalovirus  infections  in  newborn  infants.  J  Pediatr
           matching in a stroke-prevention trial in sickle cell anemia: a multicenter   98(2):281–287, 1981.
           transfusion trial. Transfusion 41(9):1086–1092, 2001.  36.  Vamvakas  EC:  Is  white  blood  cell  reduction  equivalent  to  antibody
        24.  Castro O, Sandler SG, Houston-Yu P, et al: Predicting the effect of trans-  screening  in  preventing  transmission  of  cytomegalovirus  by  transfu-
           fusing only phenotype-matched RBCs to patients with sickle cell disease:   sion?  A  review  of  the  literature  and  meta-analysis.  Transfus  Med  Rev
           theoretical and practical implications. Transfusion 42(6):684–690, 2002.  19(3):181–199, 2005.
        25.  Chou ST, Jackson T, Vege S, et al: High prevalence of red blood cell allo-  37.  Laupacis  A,  Brown  J,  Costello  B,  et al:  Prevention  of  posttransfusion
           immunization in sickle cell disease despite transfusion from Rh-matched   CMV in the era of universal WBC reduction: a consensus statement.
           minority donors. Blood 122(6):1062–1071, 2013.        Transfusion 41(4):560–569, 2001.
        26.  Olivieri NF: The beta-thalassemias. N Engl J Med 341(2):99–109, 1999.  38.  Josephson CD, Castillejo MI, Grima K, et al: ABO-mismatched platelet
        27.  Vichinsky E, Neumayr L, Trimble S, et al: Transfusion complications in   transfusions: strategies to mitigate patient exposure to naturally occurring
           thalassemia patients: a report from the Centers for Disease Control and   hemolytic antibodies. Transfus Apher Sci 42(1):83–88, 2010.
           Prevention (CME). Transfusion 54(4):972–981, quiz 1, 2014.  39.  Bada HS, Chua C, Salmon JH, et al: Changes in intracranial pressure
        28.  Aladjidi N, Leverger G, Leblanc T, et al: New insights into childhood   during exchange transfusion. J Pediatr 94(1):129–132, 1979.
           autoimmune hemolytic anemia: a French national observational study
           of 265 children. Haematologica 96(5):655–663, 2011.
   2054   2055   2056   2057   2058   2059   2060   2061   2062   2063   2064